login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
PRELUDE THERAPEUTICS INC (PRLD) Stock News
USA
- NASDAQ:PRLD -
US74065P1012
-
Common Stock
1.52
USD
+0.01 (+0.66%)
Last: 11/14/2025, 8:17:50 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
PRLD Latest News, Press Relases and Analysis
All
Press Releases
3 days ago - By: Chartmill
Prelude Therapeutics Inc. (NASDAQ:PRLD) Beats Q3 2025 Earnings Estimates and Extends Cash Runway
10 days ago - By: Chartmill
- Mentions:
EVOK
RUBI
CHAC
IHRT
...
In today's session, these stocks are experiencing unusual volume.
2 days ago - By: Benzinga
- Mentions:
ALKS
ENGN
IMMP
MLSS
...
12 Health Care Stocks Moving In Thursday's After-Market Session
3 days ago - By: Prelude Therapeutics, Incorporated
Prelude Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
3 days ago - By: Prelude Therapeutics, Incorporated
Prelude Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
3 days ago - By: The Schall Law Firm
PRLD Investors Have Opportunity to Join Prelude Therapeutics Incorporated Fraud Investigation With the Schall Law Firm
11 days ago - By: Benzinga
- Mentions:
ACET
RIGL
TEM
AKTX
...
12 Health Care Stocks Moving In Tuesday's After-Market Session
11 days ago - By: Chartmill
- Mentions:
TGE
HTZ
DENN
KFRC
...
Which stocks are experiencing notable movement on Tuesday?
11 days ago - By: Chartmill
- Mentions:
FGL
RUBI
TACO
MODD
...
On Tuesday, there are stocks with unusual volume. Let's take a look.
11 days ago - By: Chartmill
- Mentions:
TGE
HTZ
DENN
KFRC
...
Tuesday's session: top gainers and losers
11 days ago - By: Chartmill
- Mentions:
TGE
PAY
FORD
HTZ
...
These stocks are gapping in today's session
11 days ago - By: Chartmill
- Mentions:
CYD
HTZ
DENN
NSP
...
Tuesday's pre-market session: top gainers and losers
11 days ago - By: Prelude Therapeutics, Incorporated
Prelude Therapeutics Announces Strategic Business Update
11 days ago - By: Prelude Therapeutics, Incorporated
Prelude Therapeutics Announces Strategic Business Update
11 days ago - By: Prelude Therapeutics, Incorporated
- Mentions:
INCY
Prelude Therapeutics Announces Exclusive Option Agreement with Incyte to Advance Mutant Selective JAK2V617F JH2 Inhibitors
11 days ago - By: Prelude Therapeutics, Incorporated
Prelude Therapeutics Announces Exclusive Option Agreement with Incyte to Advance Mutant Selective JAK2V617F JH2 Inhibitors
11 days ago - By: Chartmill
- Mentions:
OC
SANM
NSP
SRPT
...
These stocks are moving in today's after hours session
12 days ago - By: Prelude Therapeutics, Incorporated
Prelude Therapeutics Announces Publication of Abstracts for Presentation at the American Society of Hematology 67th Annual Meeting
12 days ago - By: Prelude Therapeutics, Incorporated
Prelude Therapeutics Announces Publication of Abstracts for Presentation at the American Society of Hematology 67th Annual Meeting
a month ago - By: Prelude Therapeutics, Incorporated
Prelude Therapeutics Announces Appointment of Katina Dorton, J.D., MBA to its Board of Directors
a month ago - By: Prelude Therapeutics, Incorporated
Prelude Therapeutics Announces Appointment of Katina Dorton, J.D., MBA to its Board of Directors
3 months ago - By: The Motley Fool
Prelude Cuts Q2 Losses and Costs 13%
3 months ago - By: Prelude Therapeutics, Incorporated
Prelude Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update
3 months ago - By: Prelude Therapeutics, Incorporated
Prelude Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update
6 months ago - By: Prelude Therapeutics, Incorporated
Prelude Therapeutics to Participate in Upcoming Healthcare Conferences
6 months ago - By: Prelude Therapeutics, Incorporated
Prelude Therapeutics to Participate in Upcoming Healthcare Conferences
6 months ago - By: Prelude Therapeutics, Incorporated
Prelude Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update
6 months ago - By: Prelude Therapeutics, Incorporated
Prelude Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update
7 months ago - By: Prelude Therapeutics, Incorporated
Prelude Therapeutics to Participate in Citizens Life Sciences Conference
7 months ago - By: Prelude Therapeutics, Incorporated
Prelude Therapeutics to Participate in Citizens Life Sciences Conference
7 months ago - By: Prelude Therapeutics, Incorporated
Prelude Announces Presentations at 2025 AACR Annual Meeting
7 months ago - By: Prelude Therapeutics, Incorporated
Prelude Announces Presentations at 2025 AACR Annual Meeting
7 months ago - By: Yahoo Finance
- Mentions:
GOSS
DAWN
VIR
NUVB
...
Gossamer Bio, Inc. (GOSS): Among Stocks Under $10 that Will Triple
Please enable JavaScript to continue using this application.